Skip to main content
. 2016 Apr;11(4):549–551. doi: 10.4103/1673-5374.180761

Figure 2.

Figure 2

Protein tyrosine phosphatase receptor-type Z (PTPRZ) inhibitors are potential remyelination drugs.

The inhibition of PTPRZ stimulates the differentiation of oligodendrocyte precursor cells (OPCs) in the lesioned area and promotes remyelination. Therefore, the development of inhibitory compounds of PTPRZ enzymatic activity is promising and anticipated. For details, see the text.